Optibiotix Health expands international reach through supply agreement
15th Mar 2019 08:16
(Sharecast News) - OptiBiotix Health on Friday extended a supply agreement to broaden the supply of cholesterol-lowering capsules into Germany and several other countries.
Read moreOptiBiotix up as LPLDL gets 'safe' status in US
21st Feb 2019 11:07
(Sharecast News) - Life sciences firm OptiBiotix Health confirmed on Thursday that its wholly-owned subsidiary ProBiotix Health has had its cholesterol and blood pressure reducing 'Lactobacillus plantarum LPLDL' probiotic strain determined as 'Generally Recognized As Safe' (GRAS) by an independent expert GRAS panel in the United States.
Read moreOptibiotix revenues soar in second half
13th Feb 2019 08:46
(Sharecast News) - Optibiotix Health's annual income soared in its last trading year as the healthy food additive maker continued to commercialise its products and grow sales.
Read moreOptiBiotix gains foothold in Japan with distibution deal
11th Feb 2019 12:32
(Sharecast News) - Optibiotix Health on Monday signed an agreement appointing EIWA Trading Co. as its exclusive distributor for its cholesterol and blood pressure-reducing probiotic strain LPLDL in Japan.
Read moreOptiBiotix extends CholBiome sales channel to Russia and Kazakhstan
9th Jan 2019 08:56
(Sharecast News) - OptiBiotix Health on Wednesday entered into a three-year distribution agreement for its own-brand CholBiome products in Russia and Kazakhstan.
Read moreOptiBiotix partners with Zeon Lifesciences for India market
7th Jan 2019 15:53
(Sharecast News) - Life sciences business OptiBiotix Health has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences, it announced on Monday.
Read moreOptiBiotix's 'SlimBiome' granted medical device status and CE mark
27th Nov 2018 14:17
(Sharecast News) - Life sciences business OptiBiotix Health announced on Tuesday that its 'SlimBiome' product has been granted medical device status and a CE mark.
Read moreOptiBiotix signs distribution agreement for Greece and Cyprus
22nd Nov 2018 16:00
(Sharecast News) - Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed company to exclusively distribute and commercialise its own-label 'CholBiome' products containing its cholesterol and blood pressure reducing 'LPLDL' strain in Greece and Cyprus.
Read moreOptiBiotix enters three-year distribution deal with Bulgarian partner
26th Sep 2018 13:47
(Sharecast News) - Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed Bulgarian company to exclusively distribute and commercialise its own-label 'CholBiome' products, containing its cholesterol and blood pressure reducing 'LPLDL' strain in Bulgaria, it announced on Wednesday.
Read moreOptiBiotix inks licence agreement with Taiwanese probiotics outfit
10th Sep 2018 09:12
(Sharecast News) - OptiBiotix Health has inked a non-exclusive licence agreement for its cholesterol and blood pressure-reducing LPLDL products with Taiwanese probiotics outfit Bened Biomedical.
Read moreOptiBiotix Health signs big new US partnership
4th Sep 2018 07:31
(Sharecast News) - Life sciences business OptiBiotix Health has entered into an agreement with an unnamed US company for the use of its cholesterol-reducing 'Lactobacillus plantarum' strain as a pharmaceutical drug product, it announced on Tuesday.
Read moreOptibiotix Health swings to loss despite 'exciting' period
30th Aug 2018 09:23
(Sharecast News) - Biotechnology firm Optibiotix Health on Thursday reported that it swung to a loss for the six months ended 31 May even as it won seven new manufacturing and supply agreements across what it termed as an "exciting" period.
Read moreOptiBiotix Health invests £75,000 in The Health Weight Loss Company
3rd Jan 2017 09:54
(ShareCast News) - AIM-listed life science company OptiBiotix Health has increased its investment in its subsidiary, The Health Weight Loss Company, to support marketing and increase stock levels. The company made a £75,000 investment, which increases its stake in The Health Weight Loss Company to 6
Read moreOptiBiotix Health invests further in SkinBiotix
20th Oct 2016 11:03
(ShareCast News) - OptiBiotix Health has increased its investment in majority-owned subsidiary SkinBiotix Ltd via a £400,000 Convertible Loan Agreement. The investment provides SkinBiotix funding to complete the development and human studies for its first product application, in addition to funding
Read moreGeorgian Mining drill programme intercepts more copper and gold
20th Oct 2016 11:01
(ShareCast News) - Georgian Mining Corporation reported on Thursday that continued drilling at the Kvemo Bolnisi Project in Georgia has intercepted additional significant near-surface copper and gold sulphide mineralisation. The AIM-traded firm said the significant new drill intercepts included KED0
Read more